applications

what FSL constructs are used for

FSL constructs label cells, viruses, liposomes and surfaces in minutes, with no genetic change. That one method is now used in blood services, virology, research labs, glycobiology and therapeutics. The key published papers for each use are listed below.

Kode Technology in diagnostics and transfusion medicine

Kodecytes, red cells carrying FSL constructs, give laboratories reagent cells with a defined antigen at a controlled level. They run on the blood-grouping analysers laboratories already use.

Blood-group reagent cells

A and B FSL constructs create artificial ABO subgroups at a controlled antigen density. Peptide FSL constructs create rare screening cells, such as MUT+Mur and Miltenberger kodecytes.

Key papers

Antibody specificity and quantitation

Defined synthetic glycans on kodecytes map the fine specificity of anti-A, anti-B and anti-A,B. They also measure ABO antibodies in undiluted plasma before ABO-incompatible kidney transplantation.

Key papers

Quality control and proficiency testing

Engineered antigen levels give graded positive controls, ABO sensitivity controls and specimens for external proficiency testing.

Key papers

Teaching and competency

Reactions of known strength and specificity support student training panels and serologic grading exercises.

Key papers

Transfusion reaction models

Antigen-engineered red cells model how antibody, complement and antigen density affect red-cell survival and antibody neutralisation.

Key papers

Infection serology on blood-bank analysers

Peptide kodecytes detected SARS-CoV-2 and syphilis antibodies on routine column-agglutination analysers, in studies of donor samples. Blood services could use the same equipment for population surveillance.

Key papers

Immunoglobulin potency testing

CMV-peptide kodecytes measure the Fc function of immunoglobulin products through complement activation. It is a product quality test, not a donor screening test.

Key paper

In use: Securacell™ quality controls

Immulab's Securacell™ and Securacell™ Light immunohaematology process controls use KODE™ CA (carbohydrate antigen) technology to provide group A weak and B weak cells. They are whole-blood samples tested alongside patient samples to control ABO and RhD grouping, antibody screening, ABO sensitivity and staff competency (Immulab product catalogue, p.4). Immulab products

Kode Technology in virology and infectious diseases

FSL constructs insert into the membrane of enveloped viruses, so intact virions can be labelled without changing their proteins. Labelled viruses are called kodevirions.

Virus receptor-binding assays

FSL-biotin gives virions a universal detection handle in capture ELISAs. Recent hantavirus receptor studies used it, including a 2026 paper in Nature.

Key papers

Fluorescent labelling and imaging of viruses

Fluorescent and radiolabelled FSL constructs label influenza, VSV and measles virions directly, for microscopy and in vivo biodistribution studies.

Key papers

Virus capture on surfaces

Biotin-labelled virions can be captured on avidin- or receptor-coated surfaces, a route to sensors and immobilised-virus assays.

Key paper

HIV and pathogen-receptor research

A synthetic Gb3 analogue inhibited HIV-1 infection in vitro. A VSV/HIV pseudotype allows HIV microbicide studies without level 3 biocontainment.

Key papers

Kode Technology in research reagents and bioengineering

One step labels cells, viruses, liposomes and solid surfaces, with no genetic engineering or chemical conjugation.

The FSL method

The papers that established FSL constructs and how to use them on cell and virion membranes.

Key papers

Universal biotinylation

FSL-biotin labels cells, viruses and non-biological surfaces in one step, for streptavidin detection, capture and immobilisation.

Key papers

Fluorescent cell tracking

Fluorescent FSL constructs label cells without genetic change, for live imaging, flow cytometry and tracking of stored red cells.

Key papers

Targeted-cell enrichment for RNA sequencing

FSL-biotin built into therapeutic nanoparticles tags the cells the particles reach, so those cells can be isolated for transcriptomic analysis.

Key paper

Glycan-coated surfaces and nanofibres

FSL glycans coat paper, nanofibres and other non-biological surfaces in seconds, for printed assays and glycan-presenting materials.

Key papers

Liposomes and self-assembled particles

FSL constructs label liposomes and self-assemble into micelles and core–shell nanoparticles with a controlled ligand density.

Key papers and thesis

Kode Technology in glycobiology and immunology

Glycans presented on cells, liposomes or paper in a defined way let researchers study how antibodies, lectins and complement recognise them.

Glycan recognition and antibody fine specificity

Type-specific glycans on kodecytes and paper map which glycan structures an antibody binds, including Lewis, ABH and Forssman antigens.

Key papers

Lectins, cell adhesion and model membranes

Glycan-coated membranes and vesicles show how lectins bind and how cells and protocells adhere.

Key papers

Membrane insertion and lipid rafts

How synthetic glycolipids insert into and leave cell membranes, and how the lipid tail affects it.

Key papers

Complement and Fc biology

Kodecytes measure complement-mediated haemolysis and antibody Fc function. Lipid-linked heparan sulfate mimetics are being studied as complement inhibitors.

Key papers

Endothelium, vesicles and inflammation

Glycan probes on cells and vesicles help study endothelial adhesion, microvesicles and inflammatory cells.

Key papers

Kode Technology in therapeutic applications

Kode Technology is being developed for medicine. All therapeutic uses are investigational.

Kode Immunoeducers

Kode Immunoeducers (KIEs) are an adjuvant-like initiator of an in situ autologous cancer vaccine. The KIE supplies the immune-initiating signal; the patient's tumour supplies the tumour antigens.

Key paper

Kode Immunoeducers →

Other Kode-enabled potential therapeutics

Early research includes liposome modification and lipid-linked heparan sulfate mimetics studied as complement inhibitors.

Key paper

See the investigational product disclaimer.

Kode Technology publications: every paper

The papers above are a selection. All 101 journal papers and the conference papers are in the Kode Technology bibliography.

Work with us: a new application for Kode Technology

Commission a custom FSL construct, license Kode Technology for a new application, or extend your research with R&D constructs from our catalogue.